| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/22/2004 | US20040142000 Immune activator |
| 07/22/2004 | DE10300398A1 Verwendung von substituierten 2-Phenylbenzimidazolen als Arzneimittel Use of substituted 2-Phenylbenzimidazolen as drugs |
| 07/22/2004 | CA2708895A1 Compositions, methods and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/22/2004 | CA2512558A1 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells |
| 07/22/2004 | CA2512502A1 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds |
| 07/22/2004 | CA2511905A1 Novel cb 1 receptor inverse agonists |
| 07/22/2004 | CA2511859A1 Novel cb 1 receptor inverse agonists |
| 07/22/2004 | CA2511737A1 Body weight gain inhibitor |
| 07/22/2004 | CA2507971A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/21/2004 | EP1439176A1 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 07/21/2004 | EP1439175A1 Pyrimidine compound and medicinal composition thereof |
| 07/21/2004 | EP1439174A1 4-imidazolin-2-one compounds |
| 07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 07/21/2004 | EP1438965A1 Use of extracts from Hoodia gordonii and Hoodia lugardii for the preparation of a medicament for use in the suppression of appetite |
| 07/21/2004 | EP1438898A2 Method for maintaining an existing level of body fat and/or body weight |
| 07/21/2004 | EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 07/21/2004 | EP1438407A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 07/21/2004 | EP1438378A1 Cholesterol lowering structured lipids with omega 6 pufa |
| 07/21/2004 | EP1438377A1 Cholesterol lowering structured lipids with omega 3 pufa |
| 07/21/2004 | EP1438320A1 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 07/21/2004 | EP1438316A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 07/21/2004 | EP1438313A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 07/21/2004 | EP1438310A1 Beta-carbolin derivatives as ptp-inhibitors |
| 07/21/2004 | EP1438296A2 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438285A1 Acetic acid derivatives |
| 07/21/2004 | EP1438283A1 Dicarboxylic acid derivatives, their preparation and therapeutic use |
| 07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 07/21/2004 | EP1438068A2 Antibody inhibitors of gdf-8 and uses thereof |
| 07/21/2004 | EP1438061A2 Copolymers for suppression of autoimmune diseases, and methods of use |
| 07/21/2004 | EP1438052A1 INHIBITORS OF HUMAN PHOSPHATIDYL−INOSITOL 3−KINASE DELTA |
| 07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 07/21/2004 | EP1438047A2 Compounds for reducing excessive intake of food |
| 07/21/2004 | EP1438046A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 07/21/2004 | EP1438045A1 Use of indole and indoline derivatives in the treatment of obesity or for the reduction of food intake |
| 07/21/2004 | EP1438044A1 Bis-heteroaryl alkanes as therapeutic agents |
| 07/21/2004 | EP1438043A2 Method of reducing type 2 diabetes in high risk patients |
| 07/21/2004 | EP1438038A1 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome |
| 07/21/2004 | EP1437945A1 Use of cystathionine |
| 07/21/2004 | EP1404351A4 Carbohydrate modifying agent and drinks containing the modifying agent |
| 07/21/2004 | EP1357977B1 Chromium containing compositions for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity and reduction of hyperglycemia and hypercholesteremia |
| 07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
| 07/21/2004 | EP1254251A4 Neurosteroids as markers for alzheimer's disease |
| 07/21/2004 | EP1226137B1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/21/2004 | EP1143999B1 Lipoprotein complexes and compositions containing them |
| 07/21/2004 | EP0999843B1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 07/21/2004 | EP0937040B1 N-substituted 2-cyanopyrrolidines |
| 07/21/2004 | EP0815224B1 Receptor activation by gas6 |
| 07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
| 07/21/2004 | CN1514736A Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers |
| 07/21/2004 | CN1514732A Pharmaceutical formulation consisting of plant extract with calcium coating |
| 07/21/2004 | CN1514726A Pharmaceutical compositions |
| 07/21/2004 | CN1514725A Pharmaceutical composition comprising lipase inhibitor and sucrose fatty acid ester |
| 07/21/2004 | CN1513828A P-benzoquinone compound and its preparation method and use |
| 07/21/2004 | CN1513547A Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue |
| 07/21/2004 | CN1513545A Preparation and application of natural bioselenium |
| 07/21/2004 | CN1513540A Multiritamin amino acid oral liquid and its preparation method |
| 07/21/2004 | CN1513534A Preparation for treating diabetes and its dispensing method |
| 07/21/2004 | CN1513506A Medicine for treating diabetes peripheral nerne affection |
| 07/21/2004 | CN1513471A Injection of low molecular weight chondroitin sulfate and its prepn. method |
| 07/21/2004 | CN1513469A Regulatary factor T for cell growth, and its prepn. method |
| 07/21/2004 | CN1513463A Application of timosaponin A3 for preparing medicine for treating No.2 type diabetes mellitus |
| 07/21/2004 | CN1513455A prepn. for stopping vomitus contg. compound pentoxifylline |
| 07/21/2004 | CN1513451A Traditional chinese medicine Monascus purpureus went using Lovastatin salt as main active and its preparation component |
| 07/21/2004 | CN1513444A Medicine for treating metaboic syndrome |
| 07/21/2004 | CN1513443A Large volume injection of lysine glucose hydrochloride, and its prepn. method |
| 07/21/2004 | CN1158305C Insulin derivatives with increased zinc binding |
| 07/21/2004 | CN1158299C Substituted 4-benzylaminoquinoline, method for producing the same, medicaments containing these compounds and their use |
| 07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/21/2004 | CN1158276C Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity |
| 07/21/2004 | CN1158094C Diabetes treating medicine |
| 07/21/2004 | CN1158089C Detoxicating and hypolipemic capsule |
| 07/21/2004 | CN1158085C Fe-Ca nutrient composition and its preparation method |
| 07/21/2004 | CN1158080C Application of ligustrazine and aminoguanidin in treating II-type diabetes and its complication |
| 07/21/2004 | CN1158075C Pharmaceutical compsn. and process for its prepn. |
| 07/20/2004 | US6765022 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists |
| 07/20/2004 | US6765021 Antidiabetic agents |
| 07/20/2004 | US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
| 07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
| 07/20/2004 | US6764838 Use of parasitic biological agents for prevention and control of autoimmune diseases |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
| 07/20/2004 | CA2085555C Dual inhibitors of no synthase and cyclooxygenase, process for their preparation and therapeutical compositions containing them |
| 07/15/2004 | WO2004058970A1 Adiponectin promoter and use thereof |
| 07/15/2004 | WO2004058790A1 Nitrogen-containing heterocycic derivatives, medicinal compositions containing the same and medicinal use thereof |
| 07/15/2004 | WO2004058744A1 Derivative of 5-(4-bromophenyl)-1-(2,4-dichlorophenly)-4-ethyl-n-(piperidine-1-yl)-1h-pyrazol-3-carboxamide, the preparation and therapeutic use thereof |
| 07/15/2004 | WO2004058741A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/15/2004 | WO2004058730A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 07/15/2004 | WO2004058717A1 Isoquinolinone derivatives and their use as therapeutic agents |
| 07/15/2004 | WO2004058682A1 Selective estrogen receptor modulators |
| 07/15/2004 | WO2004058284A1 Anti-obesity ingretients from medicinal plants and their composittion |
| 07/15/2004 | WO2004058281A1 Cholesterol-reducing agent containing an n-3 fatty acid |
| 07/15/2004 | WO2004058268A2 Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders |
| 07/15/2004 | WO2004058242A1 Nutritional composition for oral use |
| 07/15/2004 | WO2004043918A3 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 07/15/2004 | WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |